4//SEC Filing
Farquharson Andrew 4
Accession 0001209191-22-007637
CIK 0001856725other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 9:41 PM ET
Size
7.7 KB
Accession
0001209191-22-007637
Insider Transaction Report
Form 4
Farquharson Andrew
Director
Transactions
- Other
Class A Common Stock
2022-02-03−827,467→ 0 total(indirect: See footnote) - Other
Class A Common Stock
2022-02-03+66,127→ 66,127 total(indirect: See footnote)
Footnotes (4)
- [F1]Biologix Partners, LP and VH Rani, LP. distributed these shares to its limited partners on a pro rata basis, for no consideration.
- [F2]Represents previously held 378,564 shares of Class A Common Stock of the Issuer ("Class A Shares") held by Biologix Partners, LP and 448,903 Class A Shares held by VH Rani, LP.
- [F3]InCube Ventures II, L.P., is the limited partner of Biologix Partners, LP and VH Rani, LP. InCube Ventures II, L.P. therefore received 12,289 Class A Shares distributed by Biologix Partners, LP and 41,495 Class A Shares distributed by VH Rani, LP. and now owns those shares directly. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F4]VH Moll, L.P., is a limited partner of VH Rani, LP. VH Moll, L.P. therefore received 12,343 Class A Shares distributed by VH Rani, LP. and now owns those shares directly. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Rani Therapeutics Holdings, Inc.
CIK 0001856725
Entity typeother
Related Parties
1- filerCIK 0001865699
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 9:41 PM ET
- Size
- 7.7 KB